Albuterol

In this video, Andrea Pappalardo, MD, discusses treatment options and combinations in pediatric asthma.

BOSTON — Patients with mild asthma lowered their severe exacerbation risk by almost half by using as-needed albuterol-budesonide, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

WASHINGTON —Tertiary care center providers generally reported similar asthma inhaler practices despite being from different disciplines, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Six batches of albuterol sulfate inhalation aerosol 90 mcg (200 metered inhalation) were voluntarily recalled by the manufacturer due to container defects that may prevent them from releasing the proper dose.

WASHINGTON — The use of single-inhaler and multiple-inhaler therapies for asthma control as needed offers a variety of pros and cons, according to a presentation at the American Thoracic Society International Conference.

In late October 2022, the FDA declared a shortage of albuterol sulfate inhalation solution 0.5%, and as of early April the shortage is still in effect, according to the administration’s website.

The FDA approved a pressurized metered-dose inhaler with a fixed-dose combination of albuterol and budesonide for use as rescue medication among patients with asthma aged 18 years and older, according to a manufacturer-issued press release.

Healio compiled the most-read news in allergy, asthma and immunology posted in November.

LOUISVILLE, Ky. — Patients treated with albuterol and budesonide experienced less asthma deteriorations and exacerbations over 12 weeks compared with patients who received the mono-components or placebo, according to DENALI study results.

LOUISVILLE, Ky. — Liability concerns prevent stakeholders from adequately stocking albuterol inhalers in Illinois schools, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.